Beverley Hargadon

11.4k total citations · 3 hit papers
39 papers, 4.9k citations indexed

About

Beverley Hargadon is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Beverley Hargadon has authored 39 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 25 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Beverley Hargadon's work include Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Beverley Hargadon is often cited by papers focused on Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Beverley Hargadon collaborates with scholars based in United Kingdom, United States and Canada. Beverley Hargadon's co-authors include Christopher E. Brightling, Ian Pavord, Andrew J. Wardlaw, Peter Bradding, Ruth H. Green, Debbie Parker, Susan McKenna, William Monteiro, M. Shelley and Pranabashis Haldar and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Immunology.

In The Last Decade

Beverley Hargadon

37 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

2009 1.4k citations Pranabashis Haldar, Christopher E. Brightling et al. profile →
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

2002 1.3k citations Ruth H. Green, Christopher E. Brightling et al. profile →
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma

2006 631 citations Beverley Hargadon, M. Shelley et al. profile →

Peers

Countries citing papers authored by Beverley Hargadon

Since Specialization

Citations

This map shows the geographic impact of Beverley Hargadon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverley Hargadon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverley Hargadon more than expected).

Fields of papers citing papers by Beverley Hargadon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverley Hargadon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverley Hargadon. The network helps show where Beverley Hargadon may publish in the future.

Co-authorship network of co-authors of Beverley Hargadon

This figure shows the co-authorship network connecting the top 25 collaborators of Beverley Hargadon. A scholar is included among the top collaborators of Beverley Hargadon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverley Hargadon. Beverley Hargadon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of inhaled corticosteroids on healthy airways 2024 ·Allergy ·Emanuele Marchi, Timothy Hinks, Matthew Richardson, Latifa Khalfaoui, Fiona A. Symon, (unknown), Rachel L. Clifford, Beverley Hargadon, Cary D. Austin, Julia L. MacIsaac, Michael S. Kobor, Salman Siddiqui, Jordan S. Mar, Joseph R. Arron, David F. Choy, Peter Bradding	2
2	Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry 2021 ·ERJ Open Research ·Wadah Ibrahim, Rebecca L. Cordell, Michael Wilde, Matthew Richardson, (unknown), (unknown), Beverley Hargadon, Robert C. Free, P. S. Monks, Christopher E. Brightling, Neil Greening, Salman Siddiqui	75
3	A Feasibility Study of a Randomized Controlled Trial of Asthma-Tailored Pulmonary Rehabilitation Compared with Usual Care in Adults with Severe Asthma 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Lindsay Apps, (unknown), Nicky Hudson, (unknown), Beverley Hargadon, Anna Murphy, Sally Singh, Peter Bradding, Ruth H. Green, Rachael A Evans	14
4	Lung Computational Models and the Role of the Small Airways in Asthma 2019 ·American Journal of Respiratory and Critical Care Medicine ·Brody H. Foy, (unknown), Rafel Bordas, Matthew Richardson, Alex Bell, Amisha Singapuri, Beverley Hargadon, Christopher E. Brightling, Kelly Burrowes, David Kay, J. R. Owers-Bradley, Salman Siddiqui	83
5	Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum 2019 ·BMC Pulmonary Medicine ·Michael A. Ghebre, (unknown), Dhananjay Desai, Beverley Hargadon, Chris Newby, Joanne Woods, Laura Rapley, (unknown), Athula Herath, Erol Gaillard, Richard May, Christopher E. Brightling	34
6	Airway pathological heterogeneity in asthma: Visualization of disease microclusters using topological data analysis 2018 ·Journal of Allergy and Clinical Immunology ·Salman Siddiqui, Aarti Shikotra, Matthew Richardson, Emma Doran, David F. Choy, Alex Bell, Cary D. Austin, Jeffrey Eastham‐Anderson, Beverley Hargadon, Joseph R. Arron, Andrew J. Wardlaw, Christopher E. Brightling, Liam G. Heaney, Peter Bradding	25
7	A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma 2017 ·The Journal of Immunology ·Aarti Shikotra, David F. Choy, Salman Siddiqui, Greer Arthur, Deepti R. Nagarkar, Guiquan Jia, Adam Wright, Chandra Ohri, Emma Doran, Claire A. Butler, Beverley Hargadon, Alexander R. Abbas, Janet Jackman, Lawren C. Wu, Liam G. Heaney, Joseph R. Arron, Peter Bradding	24
8	Mutually exclusive Th2 and Th17 bronchial gene expression signatures are associated with eosinophilia in asthma 2014 ·European Respiratory Journal ·David F. Choy, Aarti Shikotra, Salman Siddiqui, Deepti R. Nagarkar, Alexander R. Abbas, Chandra Ohri, Emma Doran, Claire A. Butler, Beverley Hargadon, M. Shelley, Lawren C. Wu, Liam G. Heaney, Joseph R. Arron, Peter Bradding	4
9	COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils 2014 ·BMC Pulmonary Medicine ·(unknown), Mona Bafadhel, Fay Hollins, Adam Wright, Beverley Hargadon, Neeta Kulkarni, Christopher E. Brightling	71
10	Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma 2014 ·Journal of Allergy and Clinical Immunology ·Chris Newby, Joshua Agbetile, Beverley Hargadon, (unknown), Ruth Green, Ian Pavord, Christopher E. Brightling, Salman Siddiqui	52
11	Effectiveness of voriconazole in the treatment of Aspergillus fumigatus–associated asthma (EVITA3 study) 2013 ·Journal of Allergy and Clinical Immunology ·Joshua Agbetile, Michelle Bourne, Abbie Fairs, Beverley Hargadon, Dhananjay Desai, (unknown), Joseph P. Morley, Peter Bradding, Christopher E. Brightling, Ruth H. Green, Pranabashis Haldar, Catherine H. Pashley, Ian Pavord, Andrew J. Wardlaw	58
12	Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. 2012 ·Leicester Research Archive (University of Leicester) ·Joshua Agbetile, Abbie Fairs, Dhananjay Desai, Beverley Hargadon, Michelle Bourne, Kugathasan Mutalithas, R. Edwards, Joseph P. Morley, (unknown), (unknown), (unknown), Ian Pavord, Peter Bradding, Christopher E. Brightling, Andrew J. Wardlaw, Catherine H. Pashley	4
13	Increased expression of immunoreactive thymic stromal lymphopoetin in severe asthma 2012 ·Journal of Allergy and Clinical Immunology ·A Shikotra, David F. Choy, Chandra Ohri, Emma Doran, (unknown), Beverley Hargadon, M. Shelley, Alexander R. Abbas, Cary D. Austin, Janet Jackman, Lidan Wu, Liam G. Heaney, Joseph R. Arron, Peter Bradding	0
14	IgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma 2010 ·American Journal of Respiratory and Critical Care Medicine ·Abbie Fairs, Joshua Agbetile, Beverley Hargadon, Michelle Bourne, William Monteiro, Christopher E. Brightling, Peter Bradding, Ruth H. Green, Kugathasan Mutalithas, Dhananjay Desai, Ian Pavord, Andrew J. Wardlaw, Catherine H. Pashley	196
15	Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial 2007 ·European Respiratory Journal ·Roshan Siva, (unknown), Christopher E. Brightling, M. Shelley, Beverley Hargadon, Susan McKenna, William Monteiro, M A Berry, Debbie Parker, Andrew J. Wardlaw, Ian Pavord	343
16	Observational study of the natural history of eosinophilic bronchitis 2005 ·Clinical & Experimental Allergy ·M A Berry, Beverley Hargadon, Susan McKenna, Dominick Shaw, (unknown), Christopher E. Brightling, Andrew J. Wardlaw, Ian Pavord	66
17	Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis 2005 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·(unknown), (unknown), Philip R. Mallinder, (unknown), Beverley Hargadon, Alistair Murray, Peter Bradding	22
18	Observational study of the natural history of eosinophilic bronchitis 2003 ·Thorax ·M A Berry, Christopher E. Brightling, Beverley Hargadon, Susan McKenna, Andrew J. Wardlaw, Ian Pavord	2
19	Induced sputum mediator concentrations in COPD 2003 ·Thorax ·SS Birring, Debbie Parker, Susan McKenna, Beverley Hargadon, Christopher E. Brightling, Ian Pavord, Peter Bradding	1
20	A placebo controlled comparison of formoterol, montelukast or higher dose of inhaled corticosteroids in subjects with symptomatic asthma despite treatment with low dose inhaled corticosteroids 2002 ·Thorax ·(unknown), Christopher E. Brightling, Susan McKenna, Beverley Hargadon, Debbie Parker, Andrew J. Wardlaw, Ian Pavord	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact